Saade Jasim | Immunology Award | Best Researcher Award

Assist Prof Dr. Saade Jasim | Immunology Award | Best Researcher Award

Assist Prof Dr. Saade Jasim, Fallujah university, Iraq

Dr. Saade Jasim is an Iraqi educator and researcher specializing in microbiology. He earned his Ph.D. from Al-Azhar University, Egypt, with expertise in anticancer nanocarriers and therapeutic applications of stem cell-derived vesicles. Dr. Jasim holds a strong academic background from Anbar and Tikrit Universities, focusing on biological sciences. His research, published in reputable journals, highlights his contributions to cancer treatment and autoimmune diseases. Fluent in Arabic and proficient in English, he excels in teamwork, time management, and handling pressure. Dr. Jasim’s technical skills include Microsoft Office and social media management. He resides in Ramadi, Iraq, dedicated to advancing education and scientific innovation. šŸ“š

 

Publication profile

ScopusĀ 

Orcid

Google Scholar

Education

Dr. Saade Jasim, an accomplished Iraqi educator and researcher, was born on February 3rd, 1989, in Ramadi, Al Anbar, Iraq. He pursued his academic journey with a strong foundation in biological sciences, earning his Ph.D. in Microbiology from Al-Azhar University, Egypt, in 2022. Prior to this, he completed a Bachelor’s degree in Microbiology from Tikrit University in 2016 and a degree in Biology from Anbar University in 2012.

 

Research Focus

Dr. Saade Jasim’s research primarily focuses on the synthesis and application of advanced nanomaterials in various biomedical and environmental contexts. šŸ§¬ His notable contributions include the development of magnetic nanocarriers for drug delivery, nanocomposites for catalytic reactions, and novel nanosorbents for environmental remediation. He explores the intersection of nanotechnology with microbiology and biotechnology, aiming to enhance therapeutic strategies and environmental sustainability. Dr. Jasim’s work also encompasses the study of mesenchymal stem cell-derived therapies for autoimmune diseases, underscoring his commitment to advancing both clinical and fundamental aspects of biomedicine. šŸŒ±

 

Publication Top Notes